Potential of Anti‐Cancer Therapy Based on Anti‐miR‐155 Oligonucleotides in Glioma and Brain Tumours

MicroRNAs are aberrantly expressed in many cancers and can exert tumour‐suppressive or oncogenic functions. As oncomirs promote growth of cancer cells and support survival during chemotherapy, thus microRNA‐silencing therapies could be a valuable approach to be associated with anticancer drugs and chemotherapy treatments. miR‐155 microRNA was found overexpressed in different types of cancer, such as leukaemias (PML, B‐cell lymphomas), lung cancer and glioblastoma. GABA‐A receptor downregulation was found correlated with glioma grading, with decreasing levels associated with higher grade of malignancies. A relationship between knock‐down of miR‐155 and re‐expression of GABRA 1 protein in vivo was recently individuated. This finding has implication on the effectiveness of RNA‐silencing approaches against miR‐155 with the scope to control proliferation and signalling pathways regulated by GABA‐A receptor. Applying microRNAs for treatment of brain tumours poses several problems, and fields to be solved are mainly the passage of the brain–blood barrier and the targeted delivery to specific cell types. Glioblastoma multiforme cells bud off microvesicles that deliver cytoplasmic contents to nearby cells. Thus, the exploitation of these mechanisms to deliver antagomir therapeutics targeting microvescicles in the brain could take the lead in the near future in the treatment for brain cancers in substitution of invasive surgical intervention.

[1]  S. Kauppinen,et al.  LNA-mediated microRNA silencing in non-human primates , 2008, Nature.

[2]  Mei Mei,et al.  Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status , 2010, Laboratory Investigation.

[3]  Andreas Petri,et al.  MicroRNA silencing in primates: towards development of novel therapeutics. , 2009, Cancer research.

[4]  Arndt Borkhardt,et al.  High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma , 2004, Genes, chromosomes & cancer.

[5]  S. Marsigliante,et al.  miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. , 2012, International journal of oncology.

[6]  Gideon Rechavi,et al.  MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. , 2008, Biochemical and biophysical research communications.

[7]  Mu-Yi Hua,et al.  Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. , 2010, Radiology.

[8]  A. Bordey,et al.  GABA increases Ca2+ in cerebellar granule cell precursors via depolarization: Implications for proliferation , 2009, IUBMB life.

[9]  Mu-Yi Hua,et al.  Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. , 2010, Neuro-oncology.

[10]  Wei Liu,et al.  MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a , 2008, Journal of Molecular Medicine.

[11]  P. Poltronieri,et al.  Non-protein coding RNA biomarkers and differential expression in cancers: a review , 2008, Journal of experimental & clinical cancer research : CR.

[12]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[13]  Anindya Dutta,et al.  The role of microRNAs in glioma initiation and progression. , 2012, Frontiers in bioscience.

[14]  Yan P. Yuan,et al.  High frequency of LMAN1 abnormalities in colorectal tumors with microsatellite instability. , 2009, Cancer research.

[15]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[16]  Shusheng Wang,et al.  AngiomiRs--key regulators of angiogenesis. , 2009, Current opinion in genetics & development.

[17]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[18]  S. Hammond.  MicroRNA therapeutics: a new niche for antisense nucleic acids. , 2006, Trends in molecular medicine.

[19]  Chaoqun Huang,et al.  Computational prediction of MicroRNAs targeting GABA receptors and experimental verification of miR-181, miR-216 and miR-203 targets in GABA-A receptor , 2012, BMC Research Notes.

[20]  J. Stenvang,et al.  Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF , 2009, Nucleic acids research.

[21]  R. Kalff,et al.  GABA binding sites: their density, their affinity to muscimol and their behaviour against neuroactive steroids in human gliomas of different degrees of malignancy , 2005, Journal of Neural Transmission / General Section JNT.

[22]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[23]  Daniel K. Bonner,et al.  Self-assembled RNA interference microsponges for efficient siRNA delivery. , 2012, Nature materials.

[24]  Y. Shoshan,et al.  Gliomas display a microRNA expression profile reminiscent of neural precursor cells. , 2010, Neuro-oncology.

[25]  A. Salviati,et al.  Genetic Association and Altered Gene Expression of Mir-155 in Multiple Sclerosis Patients , 2011, International journal of molecular sciences.

[26]  W. S. Hayward,et al.  Avian bic, a Gene Isolated from a Common Retroviral Site in Avian Leukosis Virus-Induced Lymphomas That Encodes a Noncoding RNA, Cooperates with c-myc in Lymphomagenesis and Erythroleukemogenesis , 2002, Journal of Virology.

[27]  Michael A Vogelbaum,et al.  Future of convection-enhanced delivery in the treatment of brain tumors. , 2010, Future oncology.

[28]  J. Jakobsson,et al.  Functional Studies of microRNAs in Neural Stem Cells: Problems and Perspectives , 2012, Front. Neurosci..

[29]  H. Kettenmann,et al.  Functional GABAA receptors on human glioma cells , 1998, The European journal of neuroscience.

[30]  Lucienne Juillerat-Jeanneret,et al.  The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? , 2008, Drug discovery today.

[31]  P. Steeg,et al.  Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer , 2009, Pharmaceutical Research.

[32]  Y. Shibayama,et al.  Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. , 2006, Histology and histopathology.

[33]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[34]  Alberto Riva,et al.  Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155 , 2007, Journal of Virology.

[35]  T. Vats,et al.  Targeted Brain Tumor Treatment-Current Perspectives , 2007, Drug target insights.

[36]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[37]  J. Stenvang,et al.  Inhibition of microRNA function by antimiR oligonucleotides , 2012, Silence.

[38]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[39]  M. Wolter,et al.  De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures , 2010, Oncogene.

[40]  Keith L Black,et al.  Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor. , 2004, Cancer control : journal of the Moffitt Cancer Center.

[41]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[42]  Benjamin Purow,et al.  The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? , 2011, Journal of Neuro-Oncology.

[43]  J. Benoit,et al.  Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. , 2009, Biomaterials.

[44]  Kangseok Lee,et al.  Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. , 2011, Journal of biotechnology.

[45]  Leaf Huang,et al.  Surface‐Modified LPD Nanoparticles for Tumor Targeting , 2006, Annals of the New York Academy of Sciences.

[46]  Ming Yi,et al.  Human glioma growth is controlled by microRNA-10b. , 2011, Cancer research.

[47]  Venugopal Nair,et al.  Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas , 2011, PLoS pathogens.

[48]  S. Rodriguez-Zas,et al.  Therapy-, gender- and race-specific microRNA markers, target genes and networks related to glioblastoma recurrence and survival. , 2011, Cancer genomics & proteomics.

[49]  P. Jin,et al.  Cross talk between microRNA and epigenetic regulation in adult neurogenesis , 2010, The Journal of cell biology.

[50]  Wayne Tam,et al.  Reticuloendotheliosis Virus Strain T Induces miR-155, Which Targets JARID2 and Promotes Cell Survival , 2009, Journal of Virology.